NO960653D0 - A novel pharmaceutical agent for oral administration comprising progesterone and a polyethylene glycol together with an excipient - Google Patents

A novel pharmaceutical agent for oral administration comprising progesterone and a polyethylene glycol together with an excipient

Info

Publication number
NO960653D0
NO960653D0 NO960653A NO960653A NO960653D0 NO 960653 D0 NO960653 D0 NO 960653D0 NO 960653 A NO960653 A NO 960653A NO 960653 A NO960653 A NO 960653A NO 960653 D0 NO960653 D0 NO 960653D0
Authority
NO
Norway
Prior art keywords
progesterone
excipient
polyethylene glycol
oral administration
pharmaceutical agent
Prior art date
Application number
NO960653A
Other languages
Norwegian (no)
Other versions
NO960653L (en
Inventor
Karen Susanne Gram
Annelise Jensen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO960653L publication Critical patent/NO960653L/en
Publication of NO960653D0 publication Critical patent/NO960653D0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
NO960653A 1993-08-20 1996-02-19 A novel pharmaceutical agent for oral administration comprising progesterone and a polyethylene glycol together with an excipient NO960653D0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK93950A DK95093D0 (en) 1993-08-20 1993-08-20 PHARMACEUTICAL FORMULA CONTAINING A HORMON
PCT/DK1994/000310 WO1995005807A1 (en) 1993-08-20 1994-08-19 A novel pharmaceutical for oral administration comprising progesterone and a polyethylene glycol together with an excipient

Publications (2)

Publication Number Publication Date
NO960653L NO960653L (en) 1996-02-19
NO960653D0 true NO960653D0 (en) 1996-02-19

Family

ID=8099329

Family Applications (1)

Application Number Title Priority Date Filing Date
NO960653A NO960653D0 (en) 1993-08-20 1996-02-19 A novel pharmaceutical agent for oral administration comprising progesterone and a polyethylene glycol together with an excipient

Country Status (17)

Country Link
EP (1) EP0789560A1 (en)
JP (1) JPH09501682A (en)
KR (1) KR960703570A (en)
CN (1) CN1132478A (en)
AU (1) AU7530594A (en)
BR (1) BR9407306A (en)
CA (1) CA2169840A1 (en)
CZ (1) CZ42596A3 (en)
DK (1) DK95093D0 (en)
FI (1) FI960749A (en)
HU (1) HUT74167A (en)
LT (1) LT4043B (en)
NO (1) NO960653D0 (en)
NZ (1) NZ271617A (en)
PL (1) PL313113A1 (en)
SK (1) SK19396A3 (en)
WO (1) WO1995005807A1 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2772617B1 (en) * 1997-12-19 2001-03-09 Besins Iscovesco Lab PROGESTERONE TABLET AND PROCESS FOR THE PREPARATION THEREOF
FR2775599B1 (en) * 1998-03-09 2001-08-17 Besins Iscovesco Lab PHARMACEUTICAL COMPOSITION BASED ON SYNTHESIS NATURAL PROGESTERONE AND OESTRADIOL AND PROCESS FOR PREPARING THE SAME
GB2339114B (en) * 1998-06-30 2003-03-05 Ericsson Telefon Ab L M Secure messaging in mobile telephones
IL127129A (en) * 1998-11-18 2004-06-01 Ferring Bv Method for preparation of progesterone tablets for vaginal delivery and tablets so prepared
JP4354667B2 (en) * 1999-08-31 2009-10-28 バイエル・シエーリング・ファーマ・アクチエンゲゼルシャフト Medicinal combination of ethinylestradiol and drospirenone for use as a contraceptive
US6544553B1 (en) 1999-12-28 2003-04-08 Watson Pharmaceuticals, Inc. Dosage forms and methods for oral delivery of progesterone
FI20002768A (en) * 2000-12-18 2002-06-19 Licentia Oy Entero-coated pharmaceutical compositions and their preparation
AU2002242339A1 (en) * 2002-03-14 2003-09-29 Watson Pharmaceuticals, Inc. Progesterone oral drug delivery system
AU2004234057A1 (en) * 2003-04-29 2004-11-11 Akzo Nobel N.V. Antisolvent solidification process
AU2006287925B2 (en) 2005-04-28 2012-03-01 Wyeth Compositions containing micronized tanaproget
EP2055306A1 (en) * 2007-11-05 2009-05-06 Bayer Schering Pharma AG Application of a gestagen in combination with an oestrogen and one or more pharmaceutically acceptable excipients/media for lactose-free oral contraception
US9375437B2 (en) 2010-06-18 2016-06-28 Lipocine Inc. Progesterone containing oral dosage forms and kits
US20110312928A1 (en) * 2010-06-18 2011-12-22 Lipocine Inc. Progesterone Containing Oral Dosage Forms and Related Methods
US8951996B2 (en) 2011-07-28 2015-02-10 Lipocine Inc. 17-hydroxyprogesterone ester-containing oral compositions and related methods
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
PT2782584T (en) 2011-11-23 2021-09-02 Therapeuticsmd Inc Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
RU2016143081A (en) 2014-05-22 2018-06-26 Терапьютиксмд, Инк. NATURAL COMBINED HORMONE SUBSTITUTION COMPOSITIONS AND THERAPIES
BR112017027688A2 (en) 2015-06-22 2018-09-04 Lipocine Inc ORAL COMPOSITIONS CONTAINING 17- HYDROXYPROGESTERONE ESTER AND RELATED METHODS
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862311A (en) * 1971-04-12 1975-01-21 Ciba Geigy Corp Novel method of enhancing progestational endometrial proliferation with progesterone
FR2408345A1 (en) 1976-11-30 1979-06-08 Besins Jean Louis NEW COMPOSITION WITH ANTI-CONCEPTIONAL ACTION
GB2091552A (en) 1980-09-09 1982-08-04 Carnrick G W Ltd Use of progesterone for the treatment of post-menopausal women
US4963540A (en) * 1986-04-16 1990-10-16 Maxson Wayne S Method for treatment of premenstrual syndrome
US5084277A (en) 1988-08-30 1992-01-28 Greco John C Vaginal progesterone tablet
US5116619A (en) 1988-08-30 1992-05-26 Lee Roy Morgan Vaginal progesterone tablet
WO1990008537A1 (en) * 1989-02-06 1990-08-09 Abbott Laboratories Pharmaceutical compositions for oral administration
US5223268A (en) * 1991-05-16 1993-06-29 Sterling Drug, Inc. Low solubility drug-coated bead compositions

Also Published As

Publication number Publication date
CA2169840A1 (en) 1995-03-02
DK95093D0 (en) 1993-08-20
NO960653L (en) 1996-02-19
AU7530594A (en) 1995-03-21
KR960703570A (en) 1996-08-31
LT4043B (en) 1996-09-25
PL313113A1 (en) 1996-06-10
EP0789560A1 (en) 1997-08-20
SK19396A3 (en) 1997-03-05
HU9600376D0 (en) 1996-04-29
HUT74167A (en) 1996-11-28
FI960749A0 (en) 1996-02-19
BR9407306A (en) 1996-10-08
NZ271617A (en) 1996-11-26
FI960749A (en) 1996-02-19
WO1995005807A1 (en) 1995-03-02
JPH09501682A (en) 1997-02-18
LT96010A (en) 1996-06-25
CZ42596A3 (en) 1996-06-12
CN1132478A (en) 1996-10-02

Similar Documents

Publication Publication Date Title
NO960653D0 (en) A novel pharmaceutical agent for oral administration comprising progesterone and a polyethylene glycol together with an excipient
KR950703566A (en) Thienodiazepine compound and its pharmaceutical use [THIENODIAZEPINE COMPOUND AND MEDICINAL USE THEREOF]
IS4509A (en) Inhalation device, method of dispensing pharmaceutically active substance and method of administering a dose of pharmaceutically active substance
NO893896L (en) PHARMACEUTICAL FORMULATIONS AND PROCEDURES FOR PREPARING THESE.
DK129591A (en) PHARMACEUTICAL DOSAGE FOR ORAL ADMINISTRATION, IN TERMINAL FORM AND WITH PREDICTED DELIVERY AND PROCEDURE FOR PREPARING THEREOF
ZA941002B (en) Pharmaceutical compositions in semisold form and a device for administration thereof
IS3720A7 (en) Dialkoxy-pyridinyl-benzimidazole derivatives, their method and pharmaceutical use
DE69635993D1 (en) GELATED MEDICAMENTS FOR ORAL ADMINISTRATION
ZA9511034B (en) Soft gelatin pharmaceutical dosage form
MX9203480A (en) MEDICINAL FORMULATIONS IN AEROSOL.
AU7177794A (en) Absorption enhancers for drug administration
HRP980163B1 (en) Pharmaceutical composition for the oral administration of an n-piperidinopyrazole -3-carboxamide derivative, its salts and their solvates
DK1156790T3 (en) Combinations of formoterol and motetasone furate
NO308854B1 (en) Therapeutic Compounds, Pharmaceutically Acceptable Salts and Formulations Containing the Compounds, and Uses thereof
IL127572A (en) Pharmaceutical composition and medicament for nasal administration
DK0540609T3 (en) Cephalosporins and homologs, preparations and pharmaceutical preparations
DK130389A (en) CATECHOLD DERIVATIVES AND PHARMACEUTICAL PREPARATIONS COMPREHENSIVE
NO982874D0 (en) Pharmaceutical preparations with vitamin D analogues
NO20002526D0 (en) High drug intermediate and modified-release oral dosage formulations and methods for their preparation
NO950134D0 (en) Formulations for orally administered pharmaceutical agents
NO892764L (en) MEDICINAL ADMINISTRATION FOR DRUGS.
DE69415570T2 (en) Esculetin derivatives and pharmaceutical composition
NO993921L (en) Medication for infertility and for increased fertility
HK1013700A1 (en) Medical decision-making aid and device for delivering at least one drug
LV11026A (en) A pharmaceutical composition for lowering blood pressure and retarding it